{"DataElement":{"publicId":"3129551","version":"1","preferredName":"Binet Staging System Stage","preferredDefinition":"A description of the Binet stage.","longName":"2848643v1.0:3129550v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2848643","version":"1","preferredName":"Binet Staging System Stage","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"BINET_STAGE","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2848641","version":"1","preferredName":"Binet Staging System","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue.","longName":"C20114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Binet Staging System","conceptCode":"C20114","definition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"652EF2B9-5136-25B6-E040-BB89AD430581","latestVersionIndicator":"Yes","beginDate":"2009-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-15","modifiedBy":"ONEDATA","dateModified":"2009-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224086","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1A4F-0A96-5494-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"652EF2B9-5144-25B6-E040-BB89AD430581","latestVersionIndicator":"Yes","beginDate":"2009-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3129550","version":"1","preferredName":"Binet Staging System Stage","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"BINET_STAGE","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E0790C4-610B-1269-E040-BB89AD433AAB","beginDate":"2010-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-17","modifiedBy":"ONEDATA","dateModified":"2010-08-17","deletedIndicator":"No"},{"value":"Complete remission","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"2577915","version":"1","preferredName":"Complete Remission","longName":"2577915","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD68-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1C8AB80-B50B-90A7-E040-BB89AD434090","beginDate":"2011-11-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-15","modifiedBy":"ONEDATA","dateModified":"2011-11-15","deletedIndicator":"No"},{"value":"Stage C","valueDescription":"C","ValueMeaning":{"publicId":"3628887","version":"1","preferredName":"C","longName":"3628887","preferredDefinition":"Presence of anemia (Hgb less than 10.0 g/dL) or thrombocytopenia (platelet count less than 100 x 10E9/L).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF00533-4F9C-C704-E040-BB89AD433B42","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF00533-4FB4-C704-E040-BB89AD433B42","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"ONEDATA","dateModified":"2012-11-20","deletedIndicator":"No"},{"value":"Stage A","valueDescription":"A","ValueMeaning":{"publicId":"3204428","version":"1","preferredName":"A","longName":"3204428","preferredDefinition":"Two or fewer lymphoid bearing areas enlarged, without anemia or thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EAD2E86-2591-AAC1-E040-BB89AD43794B","latestVersionIndicator":"Yes","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD5CA6D5-E938-7327-E040-BB89AD431CB2","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-31","modifiedBy":"ONEDATA","dateModified":"2012-10-31","deletedIndicator":"No"},{"value":"Stage B","valueDescription":"B","ValueMeaning":{"publicId":"3204427","version":"1","preferredName":"B","longName":"3204427","preferredDefinition":"Three or more lymphoid bearing areas enlarged, without anemia or thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EAD2E86-256E-AAC1-E040-BB89AD43794B","latestVersionIndicator":"Yes","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD5CA6D5-E94C-7327-E040-BB89AD431CB2","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-31","modifiedBy":"ONEDATA","dateModified":"2012-10-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2848644","version":"1","preferredName":"Binet Staging System Stage","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C20114:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Binet Staging System","conceptCode":"C20114","definition":"A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"652EF2B9-5158-25B6-E040-BB89AD430581","latestVersionIndicator":"Yes","beginDate":"2009-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-15","modifiedBy":"ONEDATA","dateModified":"2009-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E0790C4-60F6-1269-E040-BB89AD433AAB","latestVersionIndicator":"Yes","beginDate":"2010-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-17","modifiedBy":"KUMMEROA","dateModified":"2020-12-17","changeDescription":". 2020-12-17 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964930","version":"1","longName":"2013r1: CLL Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cll_base_prep_binet_stage","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the Binet stage?","type":"Preferred Question Text","description":"What was the Binet stage?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3129551","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalInterpretation.value WHERE PerformedDiagnosis.value = \"chronic lymphocytic leukemia(CLL)\" AND PerformedObservation.methodCode = \"Binet Staging\" AND AssessedResultRelaitonship.typeCode = \"staging\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E0790C4-613A-1269-E040-BB89AD433AAB","latestVersionIndicator":"Yes","beginDate":"2010-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-17","modifiedBy":"KUMMEROA","dateModified":"2020-12-17","changeDescription":". 2020-12-17 ak OK to release per WZ. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}